EFX
38
2
MHK
49
4
NOC
43
11
ORLY
62
2
MA
64
7
CSX
60
3
GE
67
2
HBI
59
4
EOG
58
2
NAVI
52
5
FSLR
54
7
LYB
39
2
FTI
81
5
NVDA
56
-4
CRM
67
2
AAP
24
6
NSC
60
3
PGR
65
2
AXP
71
2
CF
57
-2
EFX
38
2
MHK
49
4
NOC
43
11
ORLY
62
2
MA
64
7
CSX
60
3
GE
67
2
HBI
59
4
EOG
58
2
NAVI
52
5
FSLR
54
7
LYB
39
2
FTI
81
5
NVDA
56
-4
CRM
67
2
AAP
24
6
NSC
60
3
PGR
65
2
AXP
71
2
CF
57
-2
Financhill
Back

LakeShore Biopharma 10K Form

Sell
27

LSB
LakeShore Biopharma

Last Price:
2.42
Seasonality Move:
-11.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LSB News And Ratings

See the #1 stock for the next 7 days that we like better than LSB

LSB Financial Statistics

Sales & Book Value

Annual Sales: $80.21M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.82
Price / Book: 0

Profitability

EPS (TTM): -0.39800
Net Income (TTM): $-26.16M
Gross Margin: $63.74M
Return on Equity: 0%
Return on Assets: 0%

LakeShore Biopharma Earnings Forecast

Key LakeShore Biopharma Financial Ratios

  • The Gross Profit Margin over the past 4 years for LSB is 79.48%.
  • The Selling, General & Administrative Expenses for LSB have been equal to 74.66% of Gross Profit Margin.
  • The Research & Development expenses have been 52.81% of Revenue.
  • The Interest Expense is -10.23% of Operating Income.
  • The Net Earning history of LSB is -75.59% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

LakeShore Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: LSB
Website: lakeshorebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LSB Technical Analysis vs Fundamental Analysis

Sell
27
LakeShore Biopharma (LSB) is a Sell

Is LakeShore Biopharma a Buy or a Sell?